ICOS (CD278) Antibody MA5-16415 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

ICOS (CD278) Antibody
IHC

Immunohistochemical analysis of CD278/ICOS (CD278) using anti-CD278/ICOS (CD278) Monoclonal Antibody (Product # MA5-16415) in Reactive Lymph Node Tissue. The recommened dilution for this antibody in immunohistochemistry applications is 1:100.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
ICOS (CD278) Antibody

Thermo Fisher Scientific's ICOS (CD278) Antibody is a Rabbit monoclonal antibody. The ICOS (CD278) Antibody was generated using ICOS, and inducible T cell costimulator as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Immunohistochemistry, and Immunohistochemistry - fixed.

Product Specs
ItemICOS (CD278) Antibody
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMA5-16415
Quantity500 µL
ApplicationsImmunohistochemistry (Paraffin)
Conjugate/TagUnconjugated
FormatPBS with 1% BSA and 0.1% sodium azide; pH 7.6
PurityProtein A/G
ReactivityHuman
TargetICOS (CD278)
IsotypeIgG
CloneSP98
HostRabbit
Antibody TypePrimary
Storage Temperature-20°C
ImmunogenSynthetic peptide corresponding to the C-terminus of human CD278
NCBI Full Gene Nameinducible T cell costimulator
NCBI Gene AliasesAILIM, CD278, CVID1
ClonalityMonoclonal
StorageStore at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcomeThe British journal of dermatologyAugust 1, 2022Di Raimondo C, Rubio-Gonzalez B, Palmer J, Weisenburger DD, Zain J, Wu X, Han Z, Rosen ST, Song JY, Querfeld C.(C.Q., J.Y.S.). Tissue sections of representative specimens were chosen for IHC staining for ICOS (Cat #MA5‐16415, Invitrogen, Carlsbad, CA, USA), PD1 (NAT‐105; Cell Marque, Rocklin, CA, USA) and PD‐L1 (clone SP263,

(2) PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patientsScientific reportsNovember 14, 2016Kim HR, Ha SJ, Hong MH, Heo SJ, Koh YW, Choi EC, Kim EK, Pyo KH, Jung I, Seo D, et al.

Be the First to Write a Review!